Relay Therapeutics (RLAY) EBIT Margin (2021 - 2026)
Relay Therapeutics' EBIT Margin was -25949.71% in Q2 2026, down 14598.61 percentage points from -11351.11% a year earlier and down 23330.05 percentage points from the prior quarter.
Powered by 
Analysis
Relay Therapeutics (RLAY) EBIT Margin (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Relay Therapeutics' EBIT Margin was -2999.37% through Jun 30, 2026, up 1106.23 percentage points year-over-year; for FY2025, it came in at -1971.59%, up 1750.48 percentage points from FY2024.
- EBIT Margin shows a five-year change of -1904.09 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -3722.07% in FY2024 (-2261.96 pp), -1460.11% in FY2023 (+20210.78 pp), -21670.89% in FY2022 (-9630.68 pp) and -12040.21% in FY2021 (-11972.71 pp).
- The Q2 2026 figure marks the lowest quarterly EBIT Margin since Q2 2023.
- The best year-over-year quarter for EBIT Margin over five years was Q1 2024 (a gain of 43865.59 percentage points); the worst was Q2 2023 (a drop of 67799.56 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 28.37% |
| 10 | Relay Therapeutics | 3.72 Bn | 3.21 Bn | - | -25,949.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25,949.71% |
| Mar 31, 2026 | -2,619.67% |
| Dec 31, 2025 | -866.14% |
| Jun 30, 2025 | -11,351.11% |
| Mar 31, 2025 | -1,105.21% |
| Mar 31, 2024 | -903.00% |
| Sep 30, 2023 | -291.95% |
| Jun 30, 2023 | -89,117.65% |
| Mar 31, 2023 | -44,768.58% |
| Dec 31, 2022 | -28,794.86% |
| Sep 30, 2022 | -24,968.60% |
| Jun 30, 2022 | -21,318.08% |
| Mar 31, 2022 | -14,969.21% |
| Dec 31, 2021 | -11,944.09% |
| Sep 30, 2021 | -9,157.66% |
| Jun 30, 2021 | -22,936.02% |
| Mar 31, 2021 | -4,454.31% |
API Access
Relay Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=RLAY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "RLAY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=RLAY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();